Loader

Pathways

PathWhiz ID Pathway Meta Data

PW144858

Pw144858 View Pathway
drug action

Scopolamine Drug Metabolism Action Pathway

Homo sapiens

PW176500

Pw176500 View Pathway
metabolic

Scopolamine Predicted Metabolism Pathway

Homo sapiens
Metabolites of Scopolamine are predicted with biotransformer.

PW123941

Pw123941 View Pathway
signaling

scos

Homo sapiens

PW122241

Pw122241 View Pathway
metabolic

sddw

Andro
sffer

PW122250

Pw122250 View Pathway
metabolic

sdfsfgsdfsd

Myxococcus xanthus DK1622

PW064750

Pw064750 View Pathway
signaling

SDMA Signaling

Homo sapiens

PW146330

Pw146330 View Pathway
drug action

Sea salt Drug Metabolism Action Pathway

Homo sapiens

PW146561

Pw146561 View Pathway
drug action

Secnidazole Drug Metabolism Action Pathway

Homo sapiens

PW176175

Pw176175 View Pathway
metabolic

Secnidazole Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Secnidazole are predicted with biotransformer.

PW128413

Pw128413 View Pathway
drug action

Secobarbital Action Pathway

Homo sapiens
Secobarbital is a barbiturate derivative that serves as a short-term treatment for insomnia, offering an array of properties including anesthesia induction, anticonvulsant effects, and sedative-hypnotic capabilities. It finds use in inducing anesthesia before other general anesthetic agents and for brief surgical, diagnostic, or therapeutic procedures with limited painful stimuli. While barbiturates like secobarbital don't provide significant analgesia and might even incite excitation in the presence of pain, their metabolization primarily occurs through the hepatic microsomal enzyme system, with resultant metabolites being excreted mainly through urine, and occasionally through feces. Overdose manifestations encompass lethargy, lack of coordination, cognitive impairment, slowed speech, impaired judgment, drowsiness, shallow breathing, instability, and, in severe instances, potential progression to coma and fatality.